Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/05/19
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 08/01/18
End: 06/30/19
Due: 06/30/20
Phase: N/A
Priority: Normal
Start: 03/18/17
End: 05/18/18
Due: 05/18/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study) | NCT03446586 | Yassin Abdelghaffar Charity Center for Liver Disease and Research | user2@example.com | None | 2019-04-05 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |
| Treatment of Egyptian Hepatitis C Genotype 4 Infected Children and Adolescents With Combined Ledipasvir/Sofosbuvir | NCT03743727 | Yassin Abdelghaffar Charity Center for Liver Disease and Research | user2@example.com | None | 2018-08-01 | 2019-06-30 | 2020-06-30 | - | - | 2025-07-14 |
| Treatment of Egyptian Hepatitis C Genotype 4 Infected Children (and Adolescents) With Combined Sofosbuvir & Daclatasvir | NCT03080415 | Yassin Abdelghaffar Charity Center for Liver Disease and Research | user2@example.com | None | 2017-03-18 | 2018-05-18 | 2019-05-18 | - | - | 2025-07-14 |